CI
ALXN

Cowen Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Cowen Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,000
Closed -$735K – 308
2016
Q3 		$735K Buy
6,000
+1,500
+33% +$193K 0.04% 163
2016
Q2 		$525K Buy
4,500
+1,200
+36% +$170K 0.03% 158
2016
Q1 		$459K Hold
3,300
– – 0.02% 179
2015
Q4 		$629K Buy
3,300
+100
+3% +$17.5K 0.05% 179
2015
Q3 		$500K Sell
3,200
-1,350
-30% -$246K 0.03% 173
2015
Q2 		$823K Buy
4,550
+1,050
+30% +$181K 0.05% 171
2015
Q1 		$607K Buy
+3,500
New +$634K 0.05% 199

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Cowen Inc's ALXN Position: Q4 2016 in Review

Cowen Inc sold out of Alexion Pharmaceuticals (ALXN) in Q4 2016, closing a stake of 6,000 shares — an estimated $735K sold.

Cowen Inc first reported a position in ALXN in Q1 2015 and held it in 7 quarters. The position peaked at $823K in Q2 2015. 548 funds tracked by Wall St. Rank hold ALXN as of Q4 2016.

  • Cowen Inc reported no remaining Alexion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Cowen Inc sold 6,000 Alexion Pharmaceuticals shares in Q4 2016, an estimated $735K.
  • Cowen Inc first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 7 quarters.
  • Cowen Inc's Alexion Pharmaceuticals position peaked at $823K in Q2 2015.
  • 548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2016.

Based on Cowen Inc's 13F filing for Q4 2016, filed 13 Feb 2017.